The chemical class known as GPR89A Activators encompasses a range of compounds that are understood to influence the signaling pathways related to the G protein-coupled receptor GPR89A. These activators are not linked by a common chemical structure or specific target activity but are instead characterized by their ability to modulate cellular processes that can indirectly lead to the activation of GPR89A. The primary methods by which these chemicals can exert their influence include the alteration of intracellular second messenger concentrations, such as cyclic AMP (cAMP) or calcium ions, and the modification of protein kinase activity, which are central to the regulatory mechanisms governing GPCR function. By increasing cAMP levels, for example, some of these activators can enhance the signaling of GPCRs that respond to elevated cAMP within the cell. Others can achieve similar outcomes by inhibiting the breakdown of cAMP, thereby sustaining its action in the cell.
Moreover, certain chemicals within this class can influence the GPR89A receptor by modulating protein interactions and the phosphorylation states of proteins involved in the signaling cascade. This includes the activation or inhibition of various G proteins and kinase enzymes such as protein kinase C (PKC) and G protein-coupled receptor kinases (GRKs). Some of these activators can also impact the cytoskeletal components of the cell, potentially influencing receptor function through changes in cellular architecture or dynamics. The GPR89A Activators do not share a singular mode of action but rather represent a diverse array of molecules that can alter the cellular signaling milieu in which GPR89A operates. These compounds can be instrumental in dissecting the complex pathways and networks that govern GPCR signaling, providing valuable insights into the intricate web of intracellular communication.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates protein kinase C, which could activate GPR89A by modulating GPCR signaling cascades. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Increases intracellular calcium levels, could activate GPR89A by influencing GPCR-related signaling linked to calcium signaling. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
A non-selective inhibitor of phosphodiesterases, preventing cAMP breakdown, could activate GPR89A by affecting GPCR signaling and cAMP levels. | ||||||
Pertussis Toxin (islet-activating protein) | 70323-44-3 | sc-200837 | 50 µg | $451.00 | 3 | |
Inactivates Gi/o type G proteins, could activate GPR89A by altering signaling pathways. | ||||||
PP1 Analog II, 1NM-PP1 | 221244-14-0 | sc-203214 sc-203214A | 1 mg 5 mg | $106.00 $530.00 | 10 | |
A potent and selective inhibitor of Gs alpha subunit, could activate GPR89A by affecting cAMP levels. | ||||||
Gö 6983 | 133053-19-7 | sc-203432 sc-203432A sc-203432B | 1 mg 5 mg 10 mg | $105.00 $299.00 $474.00 | 15 | |
A broad-spectrum PKC inhibitor, could activate GPR89A by modulating various GPCR signaling cascades. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
A ROCK inhibitor, could activate GPR89A by impacting cytoskeletal arrangement and cell contractility if it's coupled to such cellular processes. | ||||||